CVE:RLV Relevium Technologies (RLV) Stock Price, News & Analysis → Protect Your Bank Account from China (From Behind the Markets) (Ad) Free RLV Stock Alerts C$0.02 0.00 (0.00%) (As of 01/7/2022) Add Compare Share Share Today's RangeC$0.02▼C$0.0250-Day RangeC$0.02▼C$0.0252-Week RangeC$0.01▼C$0.05Volume130,500 shsAverage Volume140,861 shsMarket CapitalizationC$6.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Relevium Technologies alerts: Email Address Ad Porter & CompanyThe attacks will come for me after releasing this…America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash.Click here to see how you can protect yourself today. About Relevium TechnologiesRelevium Technologies Inc. engages in the identification, evaluation, acquisition, and operation of brands and businesses in the health and wellness markets with a focus on e-commerce. The company markets dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals primarily through its Bioganix brand portfolio online; dietary supplements under the LeefyLyfe brand; and skin care products under the Push & Pull System brand. It also provides Relevium Senior, a geriatric brand targeting inflammatory conditions, including joints, heart, and brain; and Relevium Kids, a pediatric brand of nutraceuticals and oral nutritional supplements. The company was formerly known as BIOflex Technologies Inc. and changed its name to Relevium Technologies Inc. in December 2015. Relevium Technologies Inc. is headquartered in Montreal, Canada.Read More RLV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RLV Stock News HeadlinesOctober 17, 2023 | investing.comRelevium Technologies Inc (RLVh)August 11, 2022 | yahoo.comDru Hill’s Sisqo Responds To Jodeci ‘Verzuz’ Battle DebateFebruary 11, 2022 | yahoo.comRelevium Provides Operational and Continued Disclosure UpdateJanuary 5, 2022 | finance.yahoo.comRelevium Provides Bi-Weekly Update to Management Cease Trade OrderDecember 18, 2021 | financialpost.comRelevium Provides Bi-Weekly Update to Management Cease Trade Order and Shares for Debt SettlementNovember 19, 2021 | finance.yahoo.comRelevium Provides Update to Management Cease Trade Order and Other MattersNovember 1, 2021 | finance.yahoo.comRelevium Announces Delay in Filing Annual Financial StatementsOctober 26, 2021 | finance.yahoo.comRelevium Provides Corporate Update on the Transaction to Acquire BioganixOctober 1, 2021 | finance.yahoo.comRelevium Technologies Completes Shares-For-Debt TransactionsAugust 12, 2021 | au.finance.yahoo.comUPDATE 1-Robinhood to buy fintech firm Say Technologies for $140 mlnAugust 10, 2021 | financialpost.comRelevium Obtains Conditional TSXV Approval for the Settlement of the Outstanding Notes in SharesSee More Headlines Receive RLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relevium Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolCVE:RLV CUSIPN/A CIKN/A Webwww.releviumcorp.com Phone+1-514-8248559FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-2,640,000.00 Net Margins-18.50% Pretax MarginN/A Return on EquityN/A Return on Assets4.20% Debt Debt-to-Equity Ratio8,068.50 Current Ratio0.60 Quick Ratio0.02 Sales & Book Value Annual SalesC$14.25 million Price / Sales0.46 Cash FlowC$0.00 per share Price / Cash Flow20.00 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares329,490,000Free FloatN/AMarket CapC$6.59 million OptionableNot Optionable Beta1.88 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Aurelio Useche C.M.A. (Age 55)M.B.A., Pres, CEO & Director Comp: $184.42kMr. Mark Anthony Billings C.F.A. (Age 53)CFA, M.B.A., MBA, Chief Financial Officer Comp: $64kMr. Edward Ierfino B. Comm. (Age 55)Mang. of Investor Relations Mr. Abis HussainSr. Marketing OfficerKey CompetitorsFire & FlowerTSE:FAFKiaroCVE:KONeighbourly PharmacyTSE:NBLYAcasti PharmaCVE:ACSTGeneNewsTSE:GENView All Competitors RLV Stock Analysis - Frequently Asked Questions How have RLV shares performed in 2024? Relevium Technologies' stock was trading at C$0.02 at the start of the year. Since then, RLV stock has increased by 0.0% and is now trading at C$0.02. View the best growth stocks for 2024 here. What other stocks do shareholders of Relevium Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Relevium Technologies investors own include Arctic Star Exploration (ADD), Eldorado Gold (ELD), Freedom Leaf (FRLF), Macquarie Infrastructure (MIC), Spero Therapeutics (SPRO), SoFi Weekly Income ETF (TGIF), Acquired Sales (AQSP), Aphria (APHA), Aldeyra Therapeutics (ALDX). How do I buy shares of Relevium Technologies? Shares of RLV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:RLV) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine...InvestorPlace | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredRevealed: The Unknown Biotech Powering AI in HealthcareThe CEO of Google predicted this is "one of the most important things for humanity." We're standing at the ...Behind the Markets | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relevium Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Relevium Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.